CSG’s €27bn Pipeline Offers Long-Term Promise but Short-Term Cash Constraints Test the Narrative
21.05.2026 - 12:53:41 | boerse-global.de
The Czechoslovak Group is doing what armaments investors demand: churning out more shells, winning longer contracts and expanding into new geographies. Yet the company’s balance sheet is being stretched by the very production ramp that underpins its growth story, leaving the stock caught between operational momentum and market scepticism.
Shares in CSG closed at €19.57 on Thursday, up 3.20% on the day and 20.23% higher than a week earlier. The rebound, however, still leaves the stock 43.85% below its January peak. A dispute with short-seller Hunterbrook Media — which has questioned production volumes, revenue recognition and governance — continues to weigh on sentiment, though management rejects the allegations and is considering legal action.
Solid Top-Line Growth, Tighter Working Capital
First-quarter revenue reached €1.544bn, a 13.8% increase year on year, while operating EBIT came in at €372m, translating into a margin of 24.1% — comfortably within the company’s target range. Pre-tax operating cash flow improved sharply to €6m from an outflow of €470m a year earlier, but that still leaves the group generating very little cash relative to its scale.
The reason is a heavy build-up in net working capital, which climbed to €2.199bn, equivalent to 31.7% of trailing twelve-month revenue. A year ago that ratio stood at 23.2%. CSG attributes the increase to three factors: higher inventories to support a record order backlog, prepayments to lock in supplier capacity, and a build-up of receivables at the quarter end. The company’s medium-term target is to keep net working capital below 20% of sales, so the current level represents a significant deviation.
Should investors sell immediately? Or is it worth buying CSG?
Net debt stood at €2.228bn at the end of March, putting leverage at 1.3 times trailing EBITDA. Management remains committed to ending the year below that multiple.
Defence Systems Drives the Story
The core Defence Systems segment grew 26.5%, posting revenue of €1.251bn and operating EBIT of €356m. The division’s order book now stands at €17bn, and the negotiated project pipeline has swelled to €27bn — a figure that includes multi-year NATO contracts and emerging-market deals.
Munition production is accelerating. CSG’s own capacity for large-calibre shells reached over 800,000 units at the end of the quarter, up from 550,000 last year. The company targets roughly 850,000 self-produced rounds by the end of 2026, supplemented by 400,000 rounds from reactivated production lines. Long-range munition is expected to account for more than half of artillery revenue this year as procurement shifts toward extended-range 155mm shells.
Within Defence Systems, Land Systems added €173m in revenue. The broader munition business — medium and large calibre — generated €1.049bn.
Ammo+ Struggles, Then Recovers
The CSG Ammo+ segment was a weak spot. Revenue fell to €291m and operating EBIT dropped to just €13m, dragged down by soft conditions in the commercial US channel for most of the quarter. Demand picked up noticeably toward the period end, and prices stabilised. CSG had already added personnel and capacity to serve that market, which temporarily squeezed margins.
Geographic Diversification and New Ventures
CSG is reducing its reliance on Ukraine, whose share of quarterly revenue fell to around 20%. A breakdown shows: Europe excluding Ukraine €750m, Ukraine €322m, the United States €244m, and other regions €228m. NATO countries accounted for 64% of total sales.
CSG at a turning point? This analysis reveals what investors need to know now.
The company has also been building out its footprint. In Hungary it took a 49% stake in 4iG Space & Defence Technologies, giving it indirect control of 37% of Rába Automotive Holding, a military vehicle specialist. In Greece it formed a joint venture with Hellenic Defence Systems to manufacture large-calibre munition at a plant in Lavrio that already produces 155mm rounds, with plans to add calibres and upstream processes. In Southeast Asia it secured a contract worth more than $300m for over 100 armoured Patriot vehicles.
Guidance and the Next Hurdle
CSG is sticking to its full-year targets: revenue of €7.4bn to €7.6bn, an operating EBIT margin of 24% to 25%, and capital expenditure of around 8.5% of sales. First-quarter capex was just €31m, or 2.0% of revenue, with the bulk of the year’s investment scheduled for the second half as major programmes enter their main phase.
The key test will come with the half-year report on 7 August. By then investors will be watching whether the company can convert its swollen inventories and prepayments into deliveries and cash collections — and whether the margin can hold up as production scales. If the working capital bind starts to ease, the growth story remains intact. If it does not, the gap between a €27bn pipeline and a strained cash flow statement will only grow wider.
Ad
CSG Stock: New Analysis - 21 May
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
